In summary, this study demonstrates that the overexpression of LINC00511 can strongly predict a poor survival in cancer patients and that it is associated to large tumor size, lymph node metastasis, advanced clinical stage, distant metastasis and disease recurrence. This evidence concerns the gene LINC00511 and metastatic malignant neoplasm in the lymph nodes.